Evidence map›Paper›PMID 34972712›Full record

ArticleIn vivo (Athens, Greece)

Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells.

Suhayla Alnajjar, Ingo Nolte, Jan Torben Schille, Sina Sender, Nares Trakoolju, Simon Villa Perez, Dietmar Zechner, Brigitte Vollmar, Christian Junghanss, Hugo Murua Escobar

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Suhayla AlnajjarSmall Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Ingo NolteSmall Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Jan Torben SchilleSmall Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Sina SenderDivision of Medicine, Haematology, Oncology and Palliative Medicine, University of Rostock, Rostock, Germany.
Nares TrakooljuResearch Institute for Farm Animal Biology (FBN), Institute of Genome Biology, Dummerstorf, Germany.
Simon Villa PerezDivision of Medicine, Haematology, Oncology and Palliative Medicine, University of Rostock, Rostock, Germany.
Dietmar ZechnerInstitute for Experimental Surgery, University of Medicine Rostock, Rostock, Germany.
Brigitte VollmarInstitute for Experimental Surgery, University of Medicine Rostock, Rostock, Germany.
Christian JunghanssDivision of Medicine, Haematology, Oncology and Palliative Medicine, University of Rostock, Rostock, Germany.
Hugo Murua EscobarDivision of Medicine, Haematology, Oncology and Palliative Medicine, University of Rostock, Rostock, Germany; Hugo.Murua.Escobar@med.uni-rostock.de.
University of Rostock · DEResearch Institute for Farm Animal Biology (FBN) · DEUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCancer cell inoculation is routinely used to evaluate novel therapeutic approaches in vivo. However, without reporter genes enabling deep tissue imaging, study of early tumor progression and therapeutic responses is often limited. We describe the establishment and characterization of two canine cancer cell lines stably expressing red fluorescence proteins as tools for later in vivo imaging. MATERIALS AND

methodsTwo red fluorescence cell lines were generated by plasmid transfection. Fluorescence protein expression was confirmed by flow cytometry and microscopy. Deep tissue imaging was demonstrated in mice using a NightOWL LB 983. Gene expression changes after transfection were analyzed by RNAseq.

resultsBoth cell lines were detectable in vivo by subcutaneous injection of 1×106 cells. RNAseq revealed up to 2005 transfection-induced differentially expressed genes but no significant changes in cellular key pathways.

conclusionThe fluorescent cell lines provide a solid basis for future in vivo studies on canine cancer.

Indexed as

AdenocarcinomaCarcinoma, Transitional CellProstatic NeoplasmsAnimalsCell Line, TumorDogsHumansMaleMiceProstateTransfectionin vitro and in vivo imagingProstate cancerred fluorescent protein

Identifiers

PMID34972712
PMCPMC8765162
OpenAlexW4206569689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.